We don't have good data about the benefit of perioperative heparin, whereas we are getting increasingly more evidence that perioperative heparin certainly comes with a risk. "If there's an overriding ...

DENVER, CO — Patients at high risk of thromboembolism who require pacemaker or implantable cardioverter-defibrillator (ICD) surgery can safely remain onwarfarin, without interruption, rather than be ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...

Many patients receiving an ICD or a pacemaker are already receiving oral anticoagulants. Current guidelines recommend replacement of the oral anticoagulant with the temporary use of heparin as a ...

The common practice of administering heparin soon after cardioembolic stroke is associated with an increased risk for serious bleeding, according to an article in the Archives of Neurology. However, ...

Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...

low-dose subcutaneous heparin, although safer than warfarin, was ineffective for the prevention of venous thrombosis Given that low-dose subcutaneous heparin, although safer than warfarin, was ...

Following transradial coronary angiography, radial artery occlusion is more likely to occur in patients on chronic warfarin therapy but no parenteral anticoagulation compared with those receiving ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — “Interestingly, clotting events only occurred in patients on heparin-free hemodialysis and ...

Results from a phase II trial (NTC01902680) of ultrafocal brachytherapy for low/intermediate risk prostate cancer. Health-related quality of life outcomes in a phase I/II study of stereotactic ...

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared ...